A carregar...
Treatment of Newly Diagnosed Myeloma: Bortezomib-based Triplet
In this paper we review the options for the treatment of newly diagnosed myeloma in a patient who is a candidate for autologous stem cell transplantation. Bortezomib, lenalidomide, dexamethasone (VRD) has been studied in two randomized trials as first line therapy. In one of these trials, VRD demons...
Na minha lista:
| Publicado no: | Semin Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266536/ https://ncbi.nlm.nih.gov/pubmed/28061990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2016.11.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|